Skip to main content
Category

News Archive

nhlbi-nih-logo

NHLBI Funding & Research Opportunities and Announcements for December 12, 2016

By News Archive

nhlbi-nih-logo

Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices:

  • Notice of Extension of the Response Date for NOT-OD-17-015 “Strategies for 
    • NIH Data Management, Sharing, and Citation”
    • (NOT-OD-17-025) National Institutes of Health
  • Revision: Participation of the National Institute of Dental and Craniofacial 
    • Research (NIDCR) in PAR-15-282 “Multidisciplinary Studies of HIV/AIDS and 
    • Aging (R21)” 
    • (NOT-DE-17-005)
    • National Institute of Dental and Craniofacial Research
  • Request for Information (RFI): Biological Mechanisms/Pathways of the Combined 
    • Effects of Chemical and Non-chemical Stressors Associated with Atherosclerosis
    • (NOT-ES-17-003)
    • National Institute of Environmental Health Sciences
    • National Heart, Lung, and Blood Institute
  • Notice of Intent to Publish a Funding Opportunity Announcement for Catalyzing 
    • Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans 
    • (U34) 
    • (NOT-HL-16-473)
    • National Heart, Lung, and Blood Institute
  • Notice of Intent to Publish a Funding Opportunity Announcement for Catalyzing 
    • Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans 
    • (X01)
    • (NOT-HL-16-474)
    • National Heart, Lung, and Blood Institute
  • Notice of Intent to Publish a Funding Opportunity Announcement for NHLBI Early 
    • Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33)
    • (NOT-HL-16-475)
    • National Heart, Lung, and Blood Institute
  • Notice of Intent to Publish a Funding Opportunity Announcement for Sex 
    • Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33) 
    • (NOT-HL-16-477)
    • National Heart, Lung, and Blood Institute
  • Soon to be Issued Funding Opportunity for All of Us Research Program 
    • Community Engagement (OT2) 
    • (NOT-PM-17-001)
    • National Institutes of Health
  • Notice of Change to Background for RFA-RM-16-024 “Knowledge Management 
    • Center for Illuminating the Druggable Genome (U24)”
    • (NOT-RM-17-002)
    • NIH Roadmap Initiatives
  • Notice of Change to Background for RFA-RM-16-025 “Resource Dissemination and Outreach Center for Illuminating the Druggable Genome (U24)”
  • Notice of Change to Background for RFA-RM-16-026 “Data and Resource 
    • Generation Centers for Illuminating the Druggable Genome (U24)”
    • (NOT-RM-17-004)
    • NIH Roadmap Initiatives
silense-shush-pixa

Here’s what VCs and the medtech industry don’t want you to know – MedCity News

By News Archive

silense-shush-pixa

The one thing venture capitalists and the medtech industry don’t want you to know is that innovation can sometimes be used as a manipulation to evade the law.

The industry can sometimes, even knowingly, be deceptive in three very specific ways. These are: lie to government agencies, underreport adverse events, blame the employees and consumer (victims). My goal as a federal whistleblower is to explain how these at times carefully crafted lies impacts each of you.

Read More
hospital-doctor-stethascope-pixa

Medical community alarmed by global rise in diabetes cases – EurActiv.com

By News Archive

hospital-doctor-stethascope-pixa

The rise of diabetes is causing avoidable deaths and imposing substantial costs on ailing healthcare systems. Alarmed, lawmakers are attempting to improve prevention and get the emerging pandemic under control.

Diabetes is a growing healthcare challenge and one of the four priority noncommunicable diseases (NCDs), also known as chronic diseases, targeted for urgent action by world leaders.

Read More
immunomic-bhi-partnership-logo

Calling Biotech Entrepreneurs – CANCER DISCOVERY INCUBATOR AWARD AVAILABLE!

By News Archive

immunomic-bhi-partnership-logo

Cancer Research: 5 Reasons You Should Apply

  1. Free lab space: provisions, access to mouse study and technicians
  2. Mentorship: Experienced scientific team with commercial expertise and successful serial biohealth entrepreneur and team
  3. Prime location in the center of the MD Biohealth corridor
  4. $10,000 a month in support: $5,000 cash/$5,000 “in-kind”
  5. No strings attached: no equity participation or IP rights required

Immunomic Therapeutics is committed to providing a workplace that bolsters scientific ideas. The Cancer Discovery Incubator will enable and accelerate beginning ventures with the capacity for measurable change in oncology health. The goal is to empower the beneficiary to conduct proof-of-concept experiments and ultimately, attract funding, partnerships, and fuel growth.

Read More
itif-logo

Speakers Announced: RSVP for 12/15 Event on Innovation Priorities for the Trump Administration

By News Archive

itif-logo

The Trump administration will have an opportunity to reevaluate policies that affect innovation and technological development. How can federal policies promote broadband buildout, spur investment in intelligent infrastructure, encourage research and development, and advance a host of other actions that have the potential to improve productivity and the U.S. economy? Join ITIF and the Technology Policy Institute to discuss how the Trump administration can accelerate the pace of innovation in the U.S. economy.

Read More
coaptech-logo

How CoapTech turned a feeding tube innovation into a company – Technical.ly Baltimore

By News Archive

coaptech-logo

With CoapTech, Steven Tropello and Howard Carolan are working on new technology for replacing patients’ feeding tubes.

The approach, called Percutaneous Ultrasound Gastrostomy, or PUG, utilizes a device with magnets that doctors can use to guide a feeding tube into place. It also features an ultrasound that allows doctors to see what is happening inside the body as the tube as it goes to the stomach, and identify the safest site for the tube to be placed.

Read More
ey-entrepeneur-of-the-year-2015-logo

Call for nominations! Entrepreneur Of The Year 2017 Maryland

By News Archive

ey-entrepeneur-of-the-year-2015-logo

Honoring those who see past the present to define the future

The future is not granted. It is born from the imagination of entrepreneurs. If you are a successful entrepreneur or have been inspired by an enterprising trailblazer, we’d like you to submit a nomination to the EY Entrepreneur Of The Year® 2017 program.

About the Entrepreneur Of The Year Program

Since 1986, EY has celebrated the accomplishments of thousands of entrepreneurs who have shaped the way we live, work and play. We recognize and honor these inspiring individuals through the Entrepreneur Of The Year.

Over three decades, the program has grown to span more than 145 cities, in more than 60 countries, and now boasts a roster of nearly 10,000 visionary trailblazers here in the US.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.